Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01671631
Other study ID # FORECAST
Secondary ID
Status Recruiting
Phase N/A
First received August 20, 2012
Last updated August 22, 2012

Study information

Verified date August 2012
Source University Magna Graecia
Contact Ciro Indolfi, Prof
Phone +3909613647067
Email clinicaltrials-cardioumg@email.it
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Observational

Clinical Trial Summary

The assessment of non-culprit stenoses is an important issue in ACS. Adenosine administration is currently required for functional evaluation of stenosis severity using the fractional flow reserve (FFR). An alternative adenosine-independent index of coronary stenosis, the instantaneous wave-free ratio (iFR), was recently introduced.

Aim of the present study will be to evaluate the trans-stenotic instantaneous wave-free pressure gradient (iFG), the instantaneous wave-free ratio (iFR) and the fractional flow reserve (FFR) in ACS patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- age 40 to 80 years

- recent Acute Coronary Syndrome

- indication for coronary angiography

- presence of at least one non-culprit lesion requiring functional evaluation with fractional flow reserve (FFR):

Exclusion Criteria:

- Haemodynamically significant valvular disease

- controindication for Adenosin administration

- previous CABG on the index vessel

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Functional Evaluation of Non Culprit Lesions in ACS Patients

Intervention

Other:
Measurement of intracoronary pressure


Locations

Country Name City State
Italy Cardiologia Interventistica UMG Catanzaro Calabria

Sponsors (1)

Lead Sponsor Collaborator
University Magna Graecia

Country where clinical trial is conducted

Italy,